These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15789457)

  • 1. The "pill-in-the-pocket" approach to atrial fibrillation.
    Konety SH; Olshansky B
    N Engl J Med; 2005 Mar; 352(11):1150-1; author reply 1150-1. PubMed ID: 15789457
    [No Abstract]   [Full Text] [Related]  

  • 2. 'Pill-in-the-pocket' treatment for recent-onset atrial fibrillation.
    Anusionwu O; Wali A
    Heart; 2010 Oct; 96(19):1605; author reply 1605-6. PubMed ID: 20702537
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during 'pill-in-the-pocket' treatment.
    Alboni P; Botto GL; Boriani G; Russo G; Pacchioni F; Iori M; Pasanisi G; Mancini M; Mariconti B; Capucci A
    Heart; 2010 Apr; 96(7):546-9. PubMed ID: 20350992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach.
    Alboni P; Botto GL; Baldi N; Luzi M; Russo V; Gianfranchi L; Marchi P; Calzolari M; Solano A; Baroffio R; Gaggioli G
    N Engl J Med; 2004 Dec; 351(23):2384-91. PubMed ID: 15575054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Outpatient treatment of recurrent atrial fibrillation with the "pill-in-the-pocket" approach: practical aspects].
    Alboni P; Botto GL; Baldi N
    Ital Heart J Suppl; 2005 Jun; 6(6):335-40. PubMed ID: 16013424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can recent-onset atrial fibrillation be safely and successfully treated with self-administered antiarrhythmic drugs?
    Wyse DG
    Nat Clin Pract Cardiovasc Med; 2005 Mar; 2(3):132-3. PubMed ID: 16265454
    [No Abstract]   [Full Text] [Related]  

  • 7. Syncope following 'pill-in-the-pocket' treatment of atrial fibrillation with propafenone plus quinidine.
    Daniell HW
    Heart; 2011 Oct; 97(19):1626. PubMed ID: 21859741
    [No Abstract]   [Full Text] [Related]  

  • 8. Conversion of recent onset atrial fibrillation: which drug is faster?
    Conde D
    Am J Emerg Med; 2013 Sep; 31(9):1410-1. PubMed ID: 23796978
    [No Abstract]   [Full Text] [Related]  

  • 9. [Instead of long-term antiarrhythmia drug treatment--stand-by therapy for atrial fibrillation].
    Stiefelhagen P
    MMW Fortschr Med; 2010 Feb; 152(7):18. PubMed ID: 20364502
    [No Abstract]   [Full Text] [Related]  

  • 10. Flecainide and propafenone induced ST-segment elevation in patients with atrial fibrillation: clue to specificity of Brugada-type electrocardiographic changes.
    Beldner S; Lin D; Marchlinski FE
    Am J Cardiol; 2004 Nov; 94(9):1184-5. PubMed ID: 15518618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of oral 1C antiarrhythmic drugs in terminating atrial fibrillation.
    Capucci A; Villani GQ; Piepoli MF; Aschieri D
    Curr Opin Cardiol; 1999 Jan; 14(1):4-8. PubMed ID: 9932201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is newer better? Propafenone versus quinidine for conversion of atrial fibrillation.
    Daubert JP
    Cardiol J; 2009; 16(6):491-2. PubMed ID: 19950083
    [No Abstract]   [Full Text] [Related]  

  • 13. The "pill-in-the-pocket" approach to atrial fibrillation.
    Wittkowsky AK
    N Engl J Med; 2005 Mar; 352(11):1150-1; author reply 1150-1. PubMed ID: 15789456
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of efficacy, safety and cost-effectiveness of intravenous versus oral propafenone in paroxysmal atrial fibrillation].
    Zadura M; Grossmann G; Modrzewska A; Klecha T; Klepacka H; Rumiński W
    Pol Merkur Lekarski; 2001 Aug; 11(62):137-9. PubMed ID: 11757212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide.
    Capucci A; Boriani G; Botto GL; Lenzi T; Rubino I; Falcone C; Trisolino G; Della Casa S; Binetti N; Cavazza M
    Am J Cardiol; 1994 Sep; 74(5):503-5. PubMed ID: 8059737
    [No Abstract]   [Full Text] [Related]  

  • 16. Atrial fibrillation: adverse effects of "pill-in-the-pocket" treatment and propafenone-carvedilol interaction.
    Boriani G; Biffi M; Diemberger I; Domenichini G; Marziali A; Martignani C
    Int J Cardiol; 2010 Apr; 140(2):242-3; author reply 243-4. PubMed ID: 19062111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial.
    Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Piccione G; Di Giovanni N; Colletti A; Pensabene O; Lisi F; Vasquez L; Grammatico A; Boriani G;
    Am Heart J; 2008 Jan; 155(1):100-7, 107.e1. PubMed ID: 18082498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A misguided 'pill in the pocket' approach with flecainide leading to cardiac arrest.
    Kiblboeck D; Braeuer-Mocker M; Siostrzonek P; Reisinger J
    BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22927286
    [No Abstract]   [Full Text] [Related]  

  • 19. Some patients with paroxysmal atrial fibrillation should carry flecainide or propafenone to self treat.
    Camm AJ; Savelieva I
    BMJ; 2007 Mar; 334(7594):637. PubMed ID: 17379911
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intravenous flecainide administration for conversion of paroxysmal atrial fibrillation in the emergency room].
    Antonelli D; Feldman A; Freedberg NA; Darawsha A; Rosenfeld T
    Harefuah; 2006 May; 145(5):342-4, 398. PubMed ID: 16805213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.